In summary, our results revealed that OLA1 is a novel endogenous suppressor of GSK3β, and through inhibiting the GSK3β/Snail/E-cadherin signaling, OLA1 positively regulates the EMT process in lung cancer cells. This evidence concerns the gene OLA1 and lung carcinoma.